The Pharmaceuticals, Health Care and Medical sectors operate within a uniquely challenging environment characterized by the drive to innovate, changing regulatory parameters and market consolidation.
Whether in the form of healthcare reform in the US, regulatory legislation in emerging markets, or in the austerity measures of Europe, the global outlook is one of continued risks and rewards for companies who are able to operate in the right markets/segments through effective channels and with a compelling clinical/health-economic value proposition.
The myriad needs of hospitals, physicians, pharmacists and patients, combined with the pressures of national and regional healthcare policies provide additional challenges. In order to lead, pharmaceutical, Healthcare and Medical companies must anticipate and proactively plan for payer challenges by expanding and professionalizing their pricing and market access departments. Attracting and retaining skilled staff in this area can be challenging, and integration of market access and pricing in clinical development is complex.
Expandys enables Pharmaceuticals, Health Care and Medical companies compete more effectively in this crowded and complex marketplace by helping them determine what the market needs, where to focus, and the most effective methods of addressing various stakeholders requirements. Our projects in this sector represent a wide range of initiatives, including:
- Global launch pricing strategy for a breakthrough oncology drug
- Evaluating the value proposition and messaging strategy for an innovative primary care product
- US pricing and contracting strategy for a paradigm shifting primary care product
- Emerging markets landscape assessment for a specialty care product
- Mock negotiation workshop for a potential blockbuster virology product
- Reimbursement stakeholder mapping for a hospital specialty product
- Developing the payer key account management approach in several key markets.
